DE69838076D1 - Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz - Google Patents

Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz

Info

Publication number
DE69838076D1
DE69838076D1 DE69838076T DE69838076T DE69838076D1 DE 69838076 D1 DE69838076 D1 DE 69838076D1 DE 69838076 T DE69838076 T DE 69838076T DE 69838076 T DE69838076 T DE 69838076T DE 69838076 D1 DE69838076 D1 DE 69838076D1
Authority
DE
Germany
Prior art keywords
sodium ion
accelerator
prevention
treatment
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69838076T
Other languages
English (en)
Other versions
DE69838076T2 (de
Inventor
Takaya Sato
Tutomu Uehara
Ippei Yamaoka
Kozo Asagi
Masaru Kobayashi
Hideaki Kohri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE69838076D1 publication Critical patent/DE69838076D1/de
Application granted granted Critical
Publication of DE69838076T2 publication Critical patent/DE69838076T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69838076T 1997-12-25 1998-12-24 Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz Expired - Fee Related DE69838076T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35760997 1997-12-25
JP35760997 1997-12-25
PCT/JP1998/005873 WO1999033478A1 (fr) 1997-12-25 1998-12-24 Inhibiteurs d'absorption d'ions sodium, agents pour accelerer l'excretion d'ions sodium, et agents pour prevenir et traiter les maladies provoquees par une absorption excessive de chlorure de sodium

Publications (2)

Publication Number Publication Date
DE69838076D1 true DE69838076D1 (de) 2007-08-23
DE69838076T2 DE69838076T2 (de) 2008-03-20

Family

ID=18455004

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69838076T Expired - Fee Related DE69838076T2 (de) 1997-12-25 1998-12-24 Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz

Country Status (7)

Country Link
US (1) US6369043B1 (de)
EP (1) EP1043022B1 (de)
AT (1) ATE366580T1 (de)
CA (1) CA2316387A1 (de)
DE (1) DE69838076T2 (de)
NO (1) NO20003283L (de)
WO (1) WO1999033478A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027789A1 (en) * 2000-01-14 2003-02-06 Ippei Yamaoka Inhibitors against sodium ion absorption, and preventive or therapeutic agents and foods containing the same
ES2594011T3 (es) 2006-09-26 2016-12-15 Basf Beauty Care Solutions Llc Extractos de Sarcodiotheca y biofermentaciones para su uso en productos cosméticos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353890A (en) * 1979-10-24 1982-10-12 Colgate-Palmolive Company Stabilization of carrageenan-containing toothpaste
JP3194267B2 (ja) * 1990-01-09 2001-07-30 株式会社アドバンス 排塩促進組成物の製造方法
US5344844A (en) * 1990-01-09 1994-09-06 Kabushiki Kaisya Advance Salt excretion promoting composition
JP3206045B2 (ja) 1991-10-11 2001-09-04 スズキ株式会社 自動変速機の操作装置
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤

Also Published As

Publication number Publication date
ATE366580T1 (de) 2007-08-15
NO20003283D0 (no) 2000-06-22
EP1043022B1 (de) 2007-07-11
WO1999033478A1 (fr) 1999-07-08
CA2316387A1 (en) 1999-07-08
EP1043022A1 (de) 2000-10-11
US6369043B1 (en) 2002-04-09
DE69838076T2 (de) 2008-03-20
EP1043022A4 (de) 2003-07-30
NO20003283L (no) 2000-08-25

Similar Documents

Publication Publication Date Title
DE69110561T2 (de) Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
NZ503340A (en) Treatment for hairy hoof warts (papiliomatous digital dermatitis, or PDD)
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
DE69523350T2 (de) Behandlung von hyperproliferativen Gefässerkrankungen
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
DE60214376D1 (de) Zusammensetzung zur behandlung von huf- und klauenerkrankungen
DE69713485T2 (de) Medikamente für die Behandlung oder Vorbeugung von Thrombocytopenie
TR200101649T2 (tr) Piperazin türevleri.
BR9808221A (pt) Método de tratamento de tumor.
WO2002039994A3 (en) Methods for the treatment and prevention of urinary stone disease
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
DE69838076D1 (de) Hemmer der natrium-ion absorption und beschleuniger der natrium-ion exkretion als wirkstoffe zur vorbeugung oder behandlung von erkrankungen die sich ergeben aus übermässiges einnehmen von kochsalz
IL157462A0 (en) Aquatic animal treatment method and composition containing pimenta extract
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
WO2002076400A3 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
ATE428436T1 (de) Mittel zur behandlung oder prävention allergischer erkrankungen mit bearbeitetem erdnusssamen-überzug
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
ATE108063T1 (de) Heilmittel zur behandlung von toxoplasmose.
PT1156791E (pt) Bupropiona para tratar doencas virais
DE60114778D1 (de) Behandlung von infektionen in tieren
DK0505389T3 (da) Antiparasitisk præparat til animalsk anvendelse
CA1197192A (en) Burn treatment composition
OA09771A (en) Asphodelus composition for increasing white blood cell count.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee